Navigation Links
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Date:11/26/2008

tivities. The words "potentially", "anticipates", "could", "calls for" and similar expressions also identify forward-looking statements. These statements are based upon management's current expectations and are subject to risks and uncertainties, known and unknown, which could cause actual results and developments to differ materially from those expressed or implied in such statements. Factors that could affect actual results include risks associated with the possibility that the FDA does not approve our NDA or continues to delay approval; the outcome of any discussions with the FDA; and unexpected delays or additional requirements in preparation of materials for submission to the FDA as a part of our NDA filing. Forward-looking statements contained in this press release are made as of this date, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Actual events could differ materially from those anticipated in the forward-looking statements.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...SANDIEGO,Nov.25/PRNewswire-FirstCall/--ArdeaBiosci...Quart,Pharm.D.,presidentandchiefexecutiveofficer,w...ference. , ,Presentationdetailsareasfollows:,Pip...ay,December1,2009,Time:2:00p.m.EasternTime,Locatio...,http://www.corporate-ir.net/ireye/,target=,_blan...
(Date:11/24/2009)... The New York investment bank KTA...NEU) has agreed an AU$6.7 mil convertible note pri... The private placement was arranged by KTA Capital.... , New York (PRWEB) Nove...nt bank KTA Capital, LLC ("KTA Capital")...
(Date:11/24/2009)...ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-Aldri...ASDAQOMXconferenceonTuesday,December1stat1:45PMGMT...aliveaudiobroadcastovertheInternetavailableat htt...canclickthe"Webcast"icontoaccessthisfile. ,, ...ienceandHighTechnologycompany.Itschemicalandbioche...
(Date:11/24/2009)...SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neur...yfocusedondevelopingandcommercializingnovelpainman...PresidentandChiefExecutiveOfficer,isscheduledtopre...e,tobeheldDecember1-2,2009atTheNewYorkPalaceHoteli...eri,ChiefFinancialOfficer,willbeavailabletorespond...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...i, March 31 , - Books Authored by Noted Codin...mes in health care publishing, the American Medica... exclusive agreement to,co-publish International C...l,Modification (ICD-9-CM) and Healthcare Common Pr...Buck, beginning with the 2010 editions, in fall 20...
...r 3D flat panels for Operating & Exam Rooms, P...ancisco, CA (PRWEB) March 31, 2009 -- TrueVision&r...n for microsurgery, announced its new 3D 1080p fla...an Society of Cataract and Refractive Surgery. Fo...ill have 3D 1080p flat panel LCDs to display live ...
...dexis, Inc. today announced Lori Giver, Ph.D., has... Systems Biology for Codexis Bioindustrials. She ... biology, and computational biology. Dr. Giver re...dustrials Research and Development. , , Dr. Give... evolution of genes and proteins. She joined Code...
Other Biology Technology:The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books 2The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books 3TrueVision Adds 3D Flat Panel Displays to its Visualization Platform for Refractive-Cataract Surgery 2Codexis Names Lori Giver VP Systems Biology 2
(Date:11/24/2009)...4, 2009) -- The Wildlife Conservation Society (WCS... remaining population of Siberian tigers has likel... poaching and habitat loss. , WCS sa...f what needs to be done to protect remaining popul... The report was released by the Siberian Tiger Mo...
(Date:11/24/2009)...New research on bacterial communities throughout s...le temporal patterns, suggesting that scientists c...ng climate change in the polar regions. The study,...tional Academy of Sciences Early Edition, shows t...d synchronously over time, correlating with season...
(Date:11/23/2009)...ciated strain of the deadly superbug MRSAan infect...bioticsposes a far greater health threat than prev... according to a study in the December issue of Em...s easily picked up in fitness centers, schools, an...l burden of MRSA within hospitals, the report foun...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 1Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 2Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 3Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 4Congress Braces for Showdown Over Health Care Reform 51993 1Congress Braces for Showdown Over Health Care Reform 51993 2Congress Braces for Showdown Over Health Care Reform 51993 3Rabies 3A How to Protect Yourself and Your Pets 51990 1Rabies 3A How to Protect Yourself and Your Pets 51990 2
...in a previously unknown molecular mechanism that m...ng for the causes of defective organs in fetuses, ...o researchers at Cincinnati Children,s Hospital Me...15 Genes & Development , the researchers said the...in the forming organs of embryos. , "Our study he...
...iety of America is inviting all journalists to at...ry,s largest interdisciplinary conference in the f...epresentatives can register free of charge. , Th...ort & Convention Center in National Harbor, MD, ...on, DC, on the shores of the Potomac River. This y...
... in collaboration with researchers from the Univer... have identified unusual differences in the natura... corn. , The discovery, which was made by compari...n both corn and in the much-studied laboratory pla...of the world,s most important crops protects itsel...
Other Biology News:New regulatory mechanism discovered for cell identify and behavior in forming organs 2New regulatory mechanism discovered for cell identify and behavior in forming organs 3Resilience in an aging society: GSA showcases cutting-edge meeting topics 2Resilience in an aging society: GSA showcases cutting-edge meeting topics 3Resilience in an aging society: GSA showcases cutting-edge meeting topics 4Corn researchers discover novel gene shut-off mechanisms 2Corn researchers discover novel gene shut-off mechanisms 3
... user-friendly Eppendorf Thermomixer R offers maxi...s that require shaking, heating, and cooling. Its ...ed its application and temperature control ranges....modate 24 micro test tubes, are available for: 0.5...
...e DNAscope LM is a high quality microarray scanner...gy for optimal background rejection and spatial re... the only low cost microarray scanner that is upgr... Main Features: Includes control module (compute...
...venient, easy-to-use kits for arraying proteins of...n using common lab equipment. DiscoverLight Protei...protein, cell lysate or antibody in a low-density ...nitrocellulose membranes with a 384-grid template ...
...bilZyme AP Conjugate Stabilizer is an aqueous solu...ther non-toxic stabilizing chemicals in a MES buff.... This product contains a combination of 0.02% me... preservative. StabilZyme AP Conjugate Stabilizer...
Biology Products: